Skip to content

The REDUCED Trial: REDucing the Utilization of CEsarean Sections for Dystocia

The REDUCED Trial: REDucing the Utilization of CEsarean Sections for Dystocia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02874443
Acronym
REDUCED
Enrollment
88918
Registered
2016-08-22
Start date
2016-10-31
Completion date
2020-03-30
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Dystocia

Brief summary

This project is a clustered randomized controlled trial of a knowledge translation intervention of new ACOG guidelines for the diagnosis of poor progress in labor. The intent is to reduce the rate of cesarean section (CS) in first time mothers at term (\>= 37 weeks), with a vertex presenting singleton fetus, without increasing maternal or neonatal morbidity. The guidelines were developed from data from the Consortium for Safe Labor. The unit of randomization will be sites in Alberta that deliver

Detailed description

Cluster randomized controlled trial of a knowledge translation intervention of new guidelines for the diagnosis of poor progress in labor. The intervention will be randomized to centres (the clusters) in Alberta that provide intrapartum care, have facilities to perform cesarean section and deliver at least 70 primparous women annually, with stratification based on facility type and geographic location. Clustering by centre and not individual caregivers (nurses/physicians) is necessary to prevent leakage or crossover of the intervention to controls. As all participating centres will eventually receive the intervention, the biostatistician will generate a randomization into two waves. The intervention will be introduced sequentially by strata (Calgary, Edmonton, regional centres, rural centres) to the first wave hospitals in multi-week run-in periods after which those strata will be revisited for roll-out to the second wave hospitals.

Interventions

OTHERKnowledge Translation of labor management guidelines

Sponsors

University of Calgary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Centers in Alberta that provide intrapartum care, have facilities to perform cesarean section and deliver at least 70 primparous women annually

Design outcomes

Primary

MeasureTime frameDescription
Rate of Cesarean sectionat deliveryRate of Cesarean section in primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus

Secondary

MeasureTime frameDescription
Rate of blood transfusionat deliveryRate of blood transfusion for primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus
Rate of perinatal deathat deliveryRate of perinatal death for primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus
Rate of neonatal asphyxiaat deliveryNeonatal asphyxia is defined as intrapartum stillbirth or neonatal death from asphyxia (Perinatal Society of Australia and New Zealand coding) or Neonatal Intensive Care Unit admission and at least two of: a. Apgar score of ≤5 at 10 minutes; b. Mechanical ventilation or chest compressions for resuscitation within 10 minutes; c. Cord pH \< 7.00 (venous or arterial), or arterial base excess ≥ 12 at birth. Rate of neonatal asphyxia for deliveries involving primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus
Rate of moderate or severe asphyxia or meets criteria for therapeutic coolingat deliveryRate of moderate or severe asphyxia or meets criteria for therapeutic cooling for deliveries involving primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus
Rate of post partum hemorrhageat deliveryRate of post partum hemorrhage for primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus
Rate of postpartum uterine artery/pelvic artery embolizationWithin 30 days of deliveryRate of postpartum uterine artery/pelvic artery embolization for primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus
Rate of postpartum hysterectomyWithin 30 days of deliveryRate of postpartum hysterectomy for primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus
Rate of postpartum maternal intensive care unit (ICU) admissionat deliveryRate of postpartum maternal intensive care unit (ICU) admission for primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus
Rate of neonatal sepsis or suspected sepsisat deliveryRate of neonatal sepsis or suspected sepsis for deliveries involving primiparous women in labor, at term (\>= 37 weeks), with a vertex presenting singleton fetus

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026